nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—ABCB1—colon cancer	0.388	1	CbGaD
Itraconazole—CYP3A7—Irinotecan—colon cancer	0.0573	0.128	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0573	0.128	CbGbCtD
Itraconazole—CYP2B6—Irinotecan—colon cancer	0.0546	0.122	CbGbCtD
Itraconazole—CYP3A7—Vincristine—colon cancer	0.0501	0.112	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0501	0.112	CbGbCtD
Itraconazole—CYP3A5—Irinotecan—colon cancer	0.043	0.0958	CbGbCtD
Itraconazole—CYP3A5—Vincristine—colon cancer	0.0376	0.0838	CbGbCtD
Itraconazole—ABCB1—Irinotecan—colon cancer	0.028	0.0624	CbGbCtD
Itraconazole—ABCB1—Vincristine—colon cancer	0.0244	0.0545	CbGbCtD
Itraconazole—CYP3A4—Irinotecan—colon cancer	0.0168	0.0374	CbGbCtD
Itraconazole—ABCB1—Methotrexate—colon cancer	0.0148	0.033	CbGbCtD
Itraconazole—CYP3A4—Vincristine—colon cancer	0.0146	0.0327	CbGbCtD
Itraconazole—Posaconazole—ABCB1—colon cancer	0.00234	0.761	CrCbGaD
Itraconazole—Ketoconazole—ABCB1—colon cancer	0.000736	0.239	CrCbGaD
Itraconazole—Thrombocytopenia—Vincristine—colon cancer	0.000289	0.0018	CcSEcCtD
Itraconazole—Haematuria—Capecitabine—colon cancer	0.000288	0.00179	CcSEcCtD
Itraconazole—Oedema—Irinotecan—colon cancer	0.000287	0.00179	CcSEcCtD
Itraconazole—Anaphylactic shock—Irinotecan—colon cancer	0.000287	0.00179	CcSEcCtD
Itraconazole—Chest pain—Fluorouracil—colon cancer	0.000287	0.00179	CcSEcCtD
Itraconazole—Myalgia—Fluorouracil—colon cancer	0.000287	0.00179	CcSEcCtD
Itraconazole—Infection—Irinotecan—colon cancer	0.000286	0.00178	CcSEcCtD
Itraconazole—Hyperhidrosis—Vincristine—colon cancer	0.000285	0.00177	CcSEcCtD
Itraconazole—Hepatobiliary disease—Capecitabine—colon cancer	0.000285	0.00177	CcSEcCtD
Itraconazole—Discomfort—Fluorouracil—colon cancer	0.000284	0.00176	CcSEcCtD
Itraconazole—Shock—Irinotecan—colon cancer	0.000283	0.00176	CcSEcCtD
Itraconazole—Nervous system disorder—Irinotecan—colon cancer	0.000282	0.00175	CcSEcCtD
Itraconazole—Agranulocytosis—Capecitabine—colon cancer	0.000282	0.00175	CcSEcCtD
Itraconazole—Thrombocytopenia—Irinotecan—colon cancer	0.000281	0.00175	CcSEcCtD
Itraconazole—Anorexia—Vincristine—colon cancer	0.000281	0.00175	CcSEcCtD
Itraconazole—Hyperhidrosis—Irinotecan—colon cancer	0.000278	0.00173	CcSEcCtD
Itraconazole—Confusional state—Fluorouracil—colon cancer	0.000278	0.00173	CcSEcCtD
Itraconazole—Hypotension—Vincristine—colon cancer	0.000276	0.00171	CcSEcCtD
Itraconazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000275	0.00171	CcSEcCtD
Itraconazole—Oedema—Fluorouracil—colon cancer	0.000275	0.00171	CcSEcCtD
Itraconazole—Anorexia—Irinotecan—colon cancer	0.000274	0.0017	CcSEcCtD
Itraconazole—Infection—Fluorouracil—colon cancer	0.000274	0.0017	CcSEcCtD
Itraconazole—Rhinitis—Capecitabine—colon cancer	0.000272	0.00169	CcSEcCtD
Itraconazole—Hepatitis—Capecitabine—colon cancer	0.000271	0.00168	CcSEcCtD
Itraconazole—Nervous system disorder—Fluorouracil—colon cancer	0.00027	0.00168	CcSEcCtD
Itraconazole—Thrombocytopenia—Fluorouracil—colon cancer	0.00027	0.00168	CcSEcCtD
Itraconazole—Hypoaesthesia—Capecitabine—colon cancer	0.000269	0.00168	CcSEcCtD
Itraconazole—Liver function test abnormal—Methotrexate—colon cancer	0.000269	0.00167	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000269	0.00167	CcSEcCtD
Itraconazole—Pharyngitis—Capecitabine—colon cancer	0.000269	0.00167	CcSEcCtD
Itraconazole—Tachycardia—Fluorouracil—colon cancer	0.000269	0.00167	CcSEcCtD
Itraconazole—Hypotension—Irinotecan—colon cancer	0.000269	0.00167	CcSEcCtD
Itraconazole—Urinary tract disorder—Capecitabine—colon cancer	0.000267	0.00166	CcSEcCtD
Itraconazole—Insomnia—Vincristine—colon cancer	0.000267	0.00166	CcSEcCtD
Itraconazole—Oedema peripheral—Capecitabine—colon cancer	0.000267	0.00166	CcSEcCtD
Itraconazole—Connective tissue disorder—Capecitabine—colon cancer	0.000266	0.00165	CcSEcCtD
Itraconazole—Urethral disorder—Capecitabine—colon cancer	0.000265	0.00165	CcSEcCtD
Itraconazole—Paraesthesia—Vincristine—colon cancer	0.000265	0.00165	CcSEcCtD
Itraconazole—Breast disorder—Methotrexate—colon cancer	0.000263	0.00164	CcSEcCtD
Itraconazole—Anorexia—Fluorouracil—colon cancer	0.000262	0.00163	CcSEcCtD
Itraconazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000262	0.00163	CcSEcCtD
Itraconazole—Visual impairment—Capecitabine—colon cancer	0.000261	0.00162	CcSEcCtD
Itraconazole—Insomnia—Irinotecan—colon cancer	0.00026	0.00162	CcSEcCtD
Itraconazole—Paraesthesia—Irinotecan—colon cancer	0.000258	0.0016	CcSEcCtD
Itraconazole—Hypotension—Fluorouracil—colon cancer	0.000257	0.0016	CcSEcCtD
Itraconazole—Decreased appetite—Vincristine—colon cancer	0.000257	0.0016	CcSEcCtD
Itraconazole—Dyspnoea—Irinotecan—colon cancer	0.000256	0.00159	CcSEcCtD
Itraconazole—Erythema multiforme—Capecitabine—colon cancer	0.000256	0.00159	CcSEcCtD
Itraconazole—Somnolence—Irinotecan—colon cancer	0.000256	0.00159	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000255	0.00158	CcSEcCtD
Itraconazole—Fatigue—Vincristine—colon cancer	0.000255	0.00158	CcSEcCtD
Itraconazole—Eye disorder—Capecitabine—colon cancer	0.000253	0.00157	CcSEcCtD
Itraconazole—Dyspepsia—Irinotecan—colon cancer	0.000253	0.00157	CcSEcCtD
Itraconazole—Tinnitus—Capecitabine—colon cancer	0.000253	0.00157	CcSEcCtD
Itraconazole—Pain—Vincristine—colon cancer	0.000252	0.00157	CcSEcCtD
Itraconazole—Constipation—Vincristine—colon cancer	0.000252	0.00157	CcSEcCtD
Itraconazole—Cardiac disorder—Capecitabine—colon cancer	0.000251	0.00156	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000251	0.00156	CcSEcCtD
Itraconazole—Decreased appetite—Irinotecan—colon cancer	0.00025	0.00155	CcSEcCtD
Itraconazole—Insomnia—Fluorouracil—colon cancer	0.000249	0.00155	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000248	0.00154	CcSEcCtD
Itraconazole—Fatigue—Irinotecan—colon cancer	0.000248	0.00154	CcSEcCtD
Itraconazole—Paraesthesia—Fluorouracil—colon cancer	0.000247	0.00154	CcSEcCtD
Itraconazole—Pancreatitis—Methotrexate—colon cancer	0.000247	0.00154	CcSEcCtD
Itraconazole—Constipation—Irinotecan—colon cancer	0.000246	0.00153	CcSEcCtD
Itraconazole—Pain—Irinotecan—colon cancer	0.000246	0.00153	CcSEcCtD
Itraconazole—Angiopathy—Capecitabine—colon cancer	0.000246	0.00153	CcSEcCtD
Itraconazole—Dyspnoea—Fluorouracil—colon cancer	0.000245	0.00153	CcSEcCtD
Itraconazole—Somnolence—Fluorouracil—colon cancer	0.000245	0.00152	CcSEcCtD
Itraconazole—Immune system disorder—Capecitabine—colon cancer	0.000245	0.00152	CcSEcCtD
Itraconazole—Mediastinal disorder—Capecitabine—colon cancer	0.000244	0.00152	CcSEcCtD
Itraconazole—Chills—Capecitabine—colon cancer	0.000243	0.00151	CcSEcCtD
Itraconazole—Dyspepsia—Fluorouracil—colon cancer	0.000242	0.00151	CcSEcCtD
Itraconazole—Arrhythmia—Capecitabine—colon cancer	0.000242	0.0015	CcSEcCtD
Itraconazole—Abdominal discomfort—Methotrexate—colon cancer	0.000241	0.0015	CcSEcCtD
Itraconazole—Gastrointestinal pain—Vincristine—colon cancer	0.000241	0.0015	CcSEcCtD
Itraconazole—Decreased appetite—Fluorouracil—colon cancer	0.000239	0.00149	CcSEcCtD
Itraconazole—Alopecia—Capecitabine—colon cancer	0.000239	0.00149	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000238	0.00148	CcSEcCtD
Itraconazole—Mental disorder—Capecitabine—colon cancer	0.000237	0.00148	CcSEcCtD
Itraconazole—Feeling abnormal—Irinotecan—colon cancer	0.000237	0.00147	CcSEcCtD
Itraconazole—Malnutrition—Capecitabine—colon cancer	0.000236	0.00147	CcSEcCtD
Itraconazole—Neutropenia—Methotrexate—colon cancer	0.000236	0.00146	CcSEcCtD
Itraconazole—Pain—Fluorouracil—colon cancer	0.000235	0.00146	CcSEcCtD
Itraconazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000235	0.00146	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000234	0.00146	CcSEcCtD
Itraconazole—Abdominal pain—Vincristine—colon cancer	0.000233	0.00145	CcSEcCtD
Itraconazole—Body temperature increased—Vincristine—colon cancer	0.000233	0.00145	CcSEcCtD
Itraconazole—Flatulence—Capecitabine—colon cancer	0.000232	0.00144	CcSEcCtD
Itraconazole—Erectile dysfunction—Methotrexate—colon cancer	0.000232	0.00144	CcSEcCtD
Itraconazole—Dysgeusia—Capecitabine—colon cancer	0.000231	0.00144	CcSEcCtD
Itraconazole—Photosensitivity reaction—Methotrexate—colon cancer	0.00023	0.00143	CcSEcCtD
Itraconazole—Back pain—Capecitabine—colon cancer	0.000228	0.00142	CcSEcCtD
Itraconazole—Body temperature increased—Irinotecan—colon cancer	0.000227	0.00141	CcSEcCtD
Itraconazole—Abdominal pain—Irinotecan—colon cancer	0.000227	0.00141	CcSEcCtD
Itraconazole—Feeling abnormal—Fluorouracil—colon cancer	0.000227	0.00141	CcSEcCtD
Itraconazole—Pneumonia—Methotrexate—colon cancer	0.000226	0.0014	CcSEcCtD
Itraconazole—Infestation—Methotrexate—colon cancer	0.000225	0.0014	CcSEcCtD
Itraconazole—Infestation NOS—Methotrexate—colon cancer	0.000225	0.0014	CcSEcCtD
Itraconazole—Drowsiness—Methotrexate—colon cancer	0.000225	0.0014	CcSEcCtD
Itraconazole—Depression—Methotrexate—colon cancer	0.000224	0.00139	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000223	0.00138	CcSEcCtD
Itraconazole—Vision blurred—Capecitabine—colon cancer	0.000222	0.00138	CcSEcCtD
Itraconazole—Tremor—Capecitabine—colon cancer	0.000221	0.00137	CcSEcCtD
Itraconazole—Renal failure—Methotrexate—colon cancer	0.000221	0.00137	CcSEcCtD
Itraconazole—Ill-defined disorder—Capecitabine—colon cancer	0.000219	0.00136	CcSEcCtD
Itraconazole—Urticaria—Fluorouracil—colon cancer	0.000219	0.00136	CcSEcCtD
Itraconazole—Body temperature increased—Fluorouracil—colon cancer	0.000218	0.00135	CcSEcCtD
Itraconazole—Hypersensitivity—Vincristine—colon cancer	0.000217	0.00135	CcSEcCtD
Itraconazole—Haematuria—Methotrexate—colon cancer	0.000214	0.00133	CcSEcCtD
Itraconazole—Malaise—Capecitabine—colon cancer	0.000213	0.00132	CcSEcCtD
Itraconazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000212	0.00132	CcSEcCtD
Itraconazole—Vertigo—Capecitabine—colon cancer	0.000212	0.00132	CcSEcCtD
Itraconazole—Hypersensitivity—Irinotecan—colon cancer	0.000212	0.00132	CcSEcCtD
Itraconazole—Asthenia—Vincristine—colon cancer	0.000212	0.00132	CcSEcCtD
Itraconazole—Syncope—Capecitabine—colon cancer	0.000211	0.00131	CcSEcCtD
Itraconazole—Leukopenia—Capecitabine—colon cancer	0.000211	0.00131	CcSEcCtD
Itraconazole—Agranulocytosis—Methotrexate—colon cancer	0.00021	0.0013	CcSEcCtD
Itraconazole—Loss of consciousness—Capecitabine—colon cancer	0.000207	0.00129	CcSEcCtD
Itraconazole—Asthenia—Irinotecan—colon cancer	0.000206	0.00128	CcSEcCtD
Itraconazole—Cough—Capecitabine—colon cancer	0.000206	0.00128	CcSEcCtD
Itraconazole—Hypertension—Capecitabine—colon cancer	0.000204	0.00127	CcSEcCtD
Itraconazole—Hypersensitivity—Fluorouracil—colon cancer	0.000203	0.00126	CcSEcCtD
Itraconazole—Diarrhoea—Vincristine—colon cancer	0.000202	0.00126	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—colon cancer	0.000202	0.00125	CcSEcCtD
Itraconazole—Myalgia—Capecitabine—colon cancer	0.000201	0.00125	CcSEcCtD
Itraconazole—Arthralgia—Capecitabine—colon cancer	0.000201	0.00125	CcSEcCtD
Itraconazole—Chest pain—Capecitabine—colon cancer	0.000201	0.00125	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—colon cancer	0.0002	0.00124	CcSEcCtD
Itraconazole—Anxiety—Capecitabine—colon cancer	0.0002	0.00124	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000199	0.00124	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—colon cancer	0.000199	0.00124	CcSEcCtD
Itraconazole—Discomfort—Capecitabine—colon cancer	0.000198	0.00123	CcSEcCtD
Itraconazole—Urethral disorder—Methotrexate—colon cancer	0.000198	0.00123	CcSEcCtD
Itraconazole—Diarrhoea—Irinotecan—colon cancer	0.000197	0.00122	CcSEcCtD
Itraconazole—Dizziness—Vincristine—colon cancer	0.000195	0.00121	CcSEcCtD
Itraconazole—Pruritus—Fluorouracil—colon cancer	0.000195	0.00121	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—colon cancer	0.000194	0.00121	CcSEcCtD
Itraconazole—Confusional state—Capecitabine—colon cancer	0.000194	0.00121	CcSEcCtD
Itraconazole—Oedema—Capecitabine—colon cancer	0.000192	0.0012	CcSEcCtD
Itraconazole—Infection—Capecitabine—colon cancer	0.000191	0.00119	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—colon cancer	0.000191	0.00119	CcSEcCtD
Itraconazole—Dizziness—Irinotecan—colon cancer	0.00019	0.00118	CcSEcCtD
Itraconazole—Shock—Capecitabine—colon cancer	0.000189	0.00118	CcSEcCtD
Itraconazole—Nervous system disorder—Capecitabine—colon cancer	0.000189	0.00117	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Diarrhoea—Fluorouracil—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Thrombocytopenia—Capecitabine—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Tachycardia—Capecitabine—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Vomiting—Vincristine—colon cancer	0.000188	0.00117	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—colon cancer	0.000187	0.00116	CcSEcCtD
Itraconazole—Skin disorder—Capecitabine—colon cancer	0.000187	0.00116	CcSEcCtD
Itraconazole—Rash—Vincristine—colon cancer	0.000186	0.00116	CcSEcCtD
Itraconazole—Hyperhidrosis—Capecitabine—colon cancer	0.000186	0.00116	CcSEcCtD
Itraconazole—Dermatitis—Vincristine—colon cancer	0.000186	0.00116	CcSEcCtD
Itraconazole—Headache—Vincristine—colon cancer	0.000185	0.00115	CcSEcCtD
Itraconazole—Anorexia—Capecitabine—colon cancer	0.000183	0.00114	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—colon cancer	0.000183	0.00114	CcSEcCtD
Itraconazole—Vomiting—Irinotecan—colon cancer	0.000183	0.00114	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—colon cancer	0.000182	0.00113	CcSEcCtD
Itraconazole—Dizziness—Fluorouracil—colon cancer	0.000182	0.00113	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—colon cancer	0.000182	0.00113	CcSEcCtD
Itraconazole—Rash—Irinotecan—colon cancer	0.000181	0.00113	CcSEcCtD
Itraconazole—Dermatitis—Irinotecan—colon cancer	0.000181	0.00113	CcSEcCtD
Itraconazole—Chills—Methotrexate—colon cancer	0.000181	0.00112	CcSEcCtD
Itraconazole—Headache—Irinotecan—colon cancer	0.00018	0.00112	CcSEcCtD
Itraconazole—Hypotension—Capecitabine—colon cancer	0.00018	0.00112	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—colon cancer	0.000178	0.00111	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—colon cancer	0.000177	0.0011	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—colon cancer	0.000176	0.00109	CcSEcCtD
Itraconazole—Nausea—Vincristine—colon cancer	0.000175	0.00109	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000175	0.00109	CcSEcCtD
Itraconazole—Vomiting—Fluorouracil—colon cancer	0.000175	0.00109	CcSEcCtD
Itraconazole—Insomnia—Capecitabine—colon cancer	0.000174	0.00108	CcSEcCtD
Itraconazole—Rash—Fluorouracil—colon cancer	0.000174	0.00108	CcSEcCtD
Itraconazole—Dermatitis—Fluorouracil—colon cancer	0.000173	0.00108	CcSEcCtD
Itraconazole—Paraesthesia—Capecitabine—colon cancer	0.000173	0.00107	CcSEcCtD
Itraconazole—Headache—Fluorouracil—colon cancer	0.000172	0.00107	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—colon cancer	0.000172	0.00107	CcSEcCtD
Itraconazole—Dyspnoea—Capecitabine—colon cancer	0.000172	0.00107	CcSEcCtD
Itraconazole—Nausea—Irinotecan—colon cancer	0.000171	0.00106	CcSEcCtD
Itraconazole—Back pain—Methotrexate—colon cancer	0.00017	0.00106	CcSEcCtD
Itraconazole—Dyspepsia—Capecitabine—colon cancer	0.000169	0.00105	CcSEcCtD
Itraconazole—Decreased appetite—Capecitabine—colon cancer	0.000167	0.00104	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000166	0.00103	CcSEcCtD
Itraconazole—Fatigue—Capecitabine—colon cancer	0.000166	0.00103	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—colon cancer	0.000165	0.00103	CcSEcCtD
Itraconazole—Pain—Capecitabine—colon cancer	0.000165	0.00102	CcSEcCtD
Itraconazole—Constipation—Capecitabine—colon cancer	0.000165	0.00102	CcSEcCtD
Itraconazole—Nausea—Fluorouracil—colon cancer	0.000164	0.00102	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—colon cancer	0.000163	0.00101	CcSEcCtD
Itraconazole—Feeling abnormal—Capecitabine—colon cancer	0.000159	0.000986	CcSEcCtD
Itraconazole—Malaise—Methotrexate—colon cancer	0.000158	0.000984	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—colon cancer	0.000158	0.00098	CcSEcCtD
Itraconazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000157	0.000978	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—colon cancer	0.000157	0.000977	CcSEcCtD
Itraconazole—Cough—Methotrexate—colon cancer	0.000153	0.000952	CcSEcCtD
Itraconazole—Urticaria—Capecitabine—colon cancer	0.000153	0.00095	CcSEcCtD
Itraconazole—Abdominal pain—Capecitabine—colon cancer	0.000152	0.000946	CcSEcCtD
Itraconazole—Body temperature increased—Capecitabine—colon cancer	0.000152	0.000946	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—colon cancer	0.000149	0.000929	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—colon cancer	0.000149	0.000929	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—colon cancer	0.000149	0.000929	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000148	0.000923	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—colon cancer	0.000148	0.000918	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—colon cancer	0.000144	0.000898	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—colon cancer	0.000143	0.000891	CcSEcCtD
Itraconazole—Infection—Methotrexate—colon cancer	0.000142	0.000885	CcSEcCtD
Itraconazole—Hypersensitivity—Capecitabine—colon cancer	0.000142	0.000881	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—colon cancer	0.00014	0.000873	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—colon cancer	0.00014	0.000872	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—colon cancer	0.000139	0.000865	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—colon cancer	0.000138	0.000861	CcSEcCtD
Itraconazole—Asthenia—Capecitabine—colon cancer	0.000138	0.000858	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—colon cancer	0.000137	0.000849	CcSEcCtD
Itraconazole—Pruritus—Capecitabine—colon cancer	0.000136	0.000846	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—colon cancer	0.000134	0.000832	CcSEcCtD
Itraconazole—Diarrhoea—Capecitabine—colon cancer	0.000132	0.000818	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000131	0.000811	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—colon cancer	0.00013	0.000805	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—colon cancer	0.000129	0.0008	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—colon cancer	0.000128	0.000794	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—colon cancer	0.000127	0.000792	CcSEcCtD
Itraconazole—Dizziness—Capecitabine—colon cancer	0.000127	0.000791	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—colon cancer	0.000126	0.000784	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—colon cancer	0.000125	0.000774	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000124	0.000769	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—colon cancer	0.000123	0.000768	CcSEcCtD
Itraconazole—Pain—Methotrexate—colon cancer	0.000122	0.000762	CcSEcCtD
Itraconazole—Vomiting—Capecitabine—colon cancer	0.000122	0.000761	CcSEcCtD
Itraconazole—Rash—Capecitabine—colon cancer	0.000121	0.000754	CcSEcCtD
Itraconazole—Dermatitis—Capecitabine—colon cancer	0.000121	0.000754	CcSEcCtD
Itraconazole—Headache—Capecitabine—colon cancer	0.000121	0.000749	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—colon cancer	0.000118	0.000734	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—colon cancer	0.000117	0.000728	CcSEcCtD
Itraconazole—Nausea—Capecitabine—colon cancer	0.000114	0.000711	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—colon cancer	0.000114	0.000707	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—colon cancer	0.000113	0.000704	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—colon cancer	0.000113	0.000704	CcSEcCtD
Itraconazole—Hypersensitivity—Methotrexate—colon cancer	0.000106	0.000656	CcSEcCtD
Itraconazole—Asthenia—Methotrexate—colon cancer	0.000103	0.000639	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—colon cancer	0.000101	0.00063	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—colon cancer	9.8e-05	0.000609	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—colon cancer	9.47e-05	0.000589	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—colon cancer	9.11e-05	0.000566	CcSEcCtD
Itraconazole—Rash—Methotrexate—colon cancer	9.03e-05	0.000561	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—colon cancer	9.02e-05	0.000561	CcSEcCtD
Itraconazole—Headache—Methotrexate—colon cancer	8.97e-05	0.000558	CcSEcCtD
Itraconazole—Nausea—Methotrexate—colon cancer	8.51e-05	0.000529	CcSEcCtD
